Riskpilot← Back to searchSign inGet full accessDoktorama Söderhamn AB
ABActiveOrg 5568687338Rustkammaregatan 1General medical practice activities · NACE 8621Est. 201173 employees
Revenue 2024
SEK 105,1M
+3% vs 2023
EBITDA margin
6.7%
+6% vs 2023
Equity ratio
2.5%
Financial strength
Net profit 2024
SEK 0
-100% vs 2023
| Revenue | SEK 105,1M | +3% |
| EBITDA | SEK 7,1M | +6% |
| Net profit | SEK 0 | -100% |
| Total assets | SEK 20,4M | +12% |
| Equity | SEK 512K | +0% |
| Employees | 73 | — |
Legal name
Doktorama Söderhamn AB
Org number
5568687338
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
24 oktober 2011
Share capital
SEK 500 000
Employees
73 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Firman tecknas av en av ledamöterna i förening med suppleanten
Company purpose
Bolaget ska bedriva hälso- och sjukvård i form av hälsocentral, mottagning och medicinsk konsultverkamhet på Norra Hamngatan 41 i Söderhamn och bedriva hälso- och sjukvård i form av hälsocentral, mottagning och medicinsk konsultverksamhet på Rustkammargatan 1 i Söderhamn, äga och förvalta fastigheter och värdepapper och därmed förenlig verksamhet.
Address
Rustkammaregatan 1
Phone
+4627015420
Email
lena.gramer@doktorama.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 79 918 | 83 807 | 86 681 | 89 036 | 96 172 | 101 639 | 105 055 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | 8 447 | 7 018 | 5 102 | 7 687 | 6 654 | 6 386 | 6 765 | 6 720 | 6 672 | 7 081 |
| Depreciation & amort. | −544 | −473 | −444 | −442 | −390 | −260 | −292 | −296 | −281 | −251 |
| EBIT | 7 903 | 6 545 | 4 658 | 7 245 | 6 264 | 6 126 | 6 473 | 6 424 | 6 391 | 6 830 |
| Net financials | −51 | −47 | −51 | −56 | −62 | −60 | −67 | −73 | −158 | −161 |
| Profit before tax | 11 | 23 | 17 | 988 | 52 | 26 | 64 | 44 | 39 | 29 |
| Tax | −10 | −14 | −16 | −229 | −45 | −23 | −64 | −37 | −38 | −29 |
| Net profit | 1 | 9 | 1 | 759 | 7 | 3 | 0 | 7 | 1 | 0 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 11 359 | 12 099 | 15 083 | 18 642 | 17 893 | 17 682 | 18 281 | 18 354 | 18 187 | 20 442 |
| Equity | 502 | 511 | 575 | 1 334 | 1 341 | 504 | 504 | 511 | 512 | 512 |
| Long-term debt | 2 100 | 2 100 | 2 100 | 2 100 | 2 100 | 2 100 | 2 100 | 2 100 | 2 100 | 2 100 |
| Short-term debt | 8 757 | 9 488 | 12 408 | 15 208 | 14 452 | 15 078 | 15 677 | 15 743 | 15 575 | 17 830 |
| Total debt | 10 857 | 11 588 | 14 508 | 17 308 | 16 552 | 17 178 | 17 777 | 17 843 | 17 675 | 19 930 |
EBITDA margin
6.7%
This company
15.8%
Market median
-58% vs market
20152024
Equity ratio
2.5%
This company
38.2%
Market median
-93% vs market
20152024
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
20152024
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
20152024
Asset turnover
5.14×
This company
1.12×
Market median
+359% vs market
20152024
Debt / equity
38.93×
This company
0.62×
Market median
-6179% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
GL Chief Auditor | Chief Auditor | 2022 | — | — |
LE External Signatory | External Signatory | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Deputy Board Member | 2026 | — | — | |
| Chairman | 2022 | — | — | |
| Board of Directors | 2026 | — | — | |
| Chairman | 2026 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2026 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Doktorama AB | Company | 100.0% | 100.0% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Doktorama AB
Doktorama Söderhamn AB Board members of Doktorama Söderhamn AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Guy Lars-Erik Pernersten | Chief Auditor | 0 companies |
| Lena Elisabet Gramer | External Signatory | 0 companies |
| Ulf Åke Axelsson | Board of Directors | 0 companies |
| Lars Peter Erixon | Board of Directors | 0 companies |
| Rebecca Josephine Mallander | Deputy Board Member | 0 companies |
| Robert Mikael Hill | Chairman | 0 companies |
| Jonathan Per Lodenius | Board of Directors | 0 companies |
| Marie Kristina Stinnerbom | Chairman | 0 companies |
| Leif Folke Thomas Fasth | Board of Directors | 0 companies |
| Nils Eric Fleming Sjögren | Board of Directors | 0 companies |